244 related articles for article (PubMed ID: 1475888)
1. [New strategies in treatment of severe hypercholesterolemia in coronary patients: HMG-CoA reductase inhibitors and H.E.L.P.-LDL apheresis].
Thiery J; Seidel D
Versicherungsmedizin; 1992 Dec; 44(6):186-92. PubMed ID: 1475888
[TBL] [Abstract][Full Text] [Related]
2. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
Thiery J; Seidel D
Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemia.
Eisenhauer T; Armstrong VW; Schuff-Werner P; Schütz E; Thiery J; Scheler F; Seidel D
ASAIO Trans; 1989; 35(3):580-3. PubMed ID: 2597539
[TBL] [Abstract][Full Text] [Related]
4. The H.E.L.P. system: an efficient and safe method for plasma therapy in the treatment of severe hypercholesterolemia.
Seidel D
Isr J Med Sci; 1996 Jun; 32(6):407-13. PubMed ID: 8682646
[TBL] [Abstract][Full Text] [Related]
5. Therapy of severe familial heterozygous hypercholesterolemia by low-density lipoprotein apheresis with immunoadsorption: effects of the addition of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to therapy.
Jacob BG; Richter WO; Schwandt P
Clin Investig; 1993 Nov; 71(11):908-12. PubMed ID: 8312683
[TBL] [Abstract][Full Text] [Related]
6. [Maximal therapy of hypercholesterolemia in coronary heart disease].
Thiery J; Armstrong V; Bosch T; Eisenhauer T; Schuff-Werner P; Seidel D
Ther Umsch; 1990 Jun; 47(6):520-9. PubMed ID: 2375008
[TBL] [Abstract][Full Text] [Related]
7. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
Seidel D
Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
[TBL] [Abstract][Full Text] [Related]
8. Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment.
Mellwig KP; van Buuren F; Schmidt HK; Wielepp P; Burchert W; Horstkotte D
Ther Apher Dial; 2006 Dec; 10(6):510-7. PubMed ID: 17199883
[TBL] [Abstract][Full Text] [Related]
9. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre.
Mickiewicz A; Borowiec-Wolna J; Bachorski W; Gilis-Malinowska N; Gałąska R; Raczak G; Chmara M; Wasąg B; Jaguszewski MJ; Fijałkowski M; Gruchała M
Cardiol J; 2019; 26(6):669-679. PubMed ID: 30234904
[TBL] [Abstract][Full Text] [Related]
10. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.
Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L
J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070
[TBL] [Abstract][Full Text] [Related]
11. LDL cholesterol apheresis by dextran sulfate cellulose adsorption. Long-term experience in patients with familial hypercholesterolemia.
Olbricht CJ; Schulzeck P
ASAIO Trans; 1991; 37(3):M492-3. PubMed ID: 1751248
[TBL] [Abstract][Full Text] [Related]
12. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
Koizumi J; Koizumi I; Uno Y; Inazu A; Kajinami K; Haraki T; Yagi K; Kamon N; Miyamoto S; Takegoshi T
Atherosclerosis; 1993 Apr; 100(1):65-74. PubMed ID: 8318064
[TBL] [Abstract][Full Text] [Related]
13. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
[TBL] [Abstract][Full Text] [Related]
14. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
Schuff-Werner P
Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722
[TBL] [Abstract][Full Text] [Related]
15. [Reducing low density lipoprotein-cholesterol levels by apheresis].
Reiber I; Gógl A
Orv Hetil; 1994 Mar; 135(11):563-8. PubMed ID: 8159408
[TBL] [Abstract][Full Text] [Related]
16. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities.
Vuorio A; Watts GF; Schneider WJ; Tsimikas S; Kovanen PT
J Intern Med; 2020 Jan; 287(1):2-18. PubMed ID: 31858669
[TBL] [Abstract][Full Text] [Related]
18. Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia.
Taylan C; Schlune A; Meissner T; Ažukaitis K; Udink Ten Cate FE; Weber LT
J Clin Lipidol; 2016; 10(6):1303-1310. PubMed ID: 27919346
[TBL] [Abstract][Full Text] [Related]
19. [Low density lipoprotein apheresis].
Zaliūnas R; Slapikas R; Gustiene O; Siurkus J; Vaitkus E
Medicina (Kaunas); 2003; 39(12):1158-64. PubMed ID: 14704503
[TBL] [Abstract][Full Text] [Related]
20. [Coronary revascularization with reduction of serum cholesterol level using LDL apheresis in patient with homozygous familial hypercholesterolemia].
Takahashi T; Ihara K; Matsumiya G; Mizutani S; Hasegawa J; Sato S; Nakamura T; Kawamoto T; Nagai Y; Arai T
Kokyu To Junkan; 1990 Sep; 38(9):925-30. PubMed ID: 2236967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]